Rosamund Stone Zander Translational Neuroscience Center

What Rosamund Stone Zander Translational Neuroscience Center does

The Rosamund Stone Zander Translational Neuroscience Center (RSZ TNC) is a nonprofit translational research organization founded in 2013 by Mustafa Sahin and affiliated with Boston Children's Hospital and Harvard Medical School, headquartered at 2 Brookline Place in Brookline, Massachusetts. The center's mission is to accelerate the development of therapeutic options for children with brain disorders by structuring the translation of preclinical discoveries into clinical trial readiness across neurodevelopmental disorders including autism spectrum disorder, CDKL5 deficiency, Down syndrome, Fragile X syndrome, Rett syndrome, Phelan-McDermid syndrome, SYNGAP1-related disorder, tuberous sclerosis complex, and others.

Name

Rosamund Stone Zander Translational Neuroscience Center

Legal name

Rosamund Stone Zander Translational Neuroscience Center

Website

https://rsztnc.org

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

51–100 employees

Short description

The Rosamund Stone Zander Translational Neuroscience Center is a nonprofit research center affiliated with Boston Children's Hospital and Harvard Medical School that accelerates therapeutic development for children with neurodevelopmental disorders through translational research, clinical studies, and a 35+ partner advocacy network.

Ownership category

akta.pro rank

Product category

Translational Neuroscience Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Neurogenetics & Rare Neurologic Diseases (HLAKAIAO)

akta.pro secondary industries

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA), Neurology/CNS Gene Therapies (HLAAACAH), Neurology & Psychiatry (CNS) Pharmaceuticals (HLAIAAAF)

Keywords

• Translational neuroscience research
• Pediatric neurology research
• Clinical research services
• Rare disease research
• Neurodevelopmental disorder research

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Research Funding and Grants: The center operates as a nonprofit research institution primarily funded through grants, donations, and institutional support from Boston Children's Hospital and Harvard Medical School. Revenue is not generated from commercial product sales.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

The RSZ TNC is a nonprofit translational neuroscience research center that accelerates the development of therapeutic options for children with brain disorders. It provides a Clinical Research Unit, Core Facilities (including imaging and genomics), Pilot Grants, Fellowships, and a Psychology Practicum, supported by structured frameworks (Discovery Cycle, Preclinical Roadmap, GENE TARGET Framework) that guide drug development from target identification through clinical trial readiness. The center partners with Boston Children's Hospital, Harvard Medical School, and over 35 patient advocacy groups across 19 specific neurodevelopmental disorder conditions.

Product overview

The Rosamund Stone Zander Translational Neuroscience Center (TNC) is a research-focused organization that does not offer commercial products but provides research services and infrastructure to accelerate therapeutic development for children with brain disorders. The center operates as a unified platform of interconnected research services including Core Facilities offering specialized laboratory equipment, a Clinical Research Unit for human studies, Pilot Grants for funding innovative research, Fellowships for training researchers, Psychology Practicum for clinical training, Discovery Cycle for drug development guidance, Preclinical Roadmap for study design, and the GENE TARGET Framework for gene therapy development. These services collectively support the translational research pipeline from basic science through clinical application.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Unit Clinical research infrastructure enabling the conduct of clinical trials and studies involving human subjects for translational neuroscience research in neurodevelopmental disorders. The unit supports patient enrollment, study operations, and clinical research activities for scientists and patient families.
• Core Facilities (Research Services) Laboratory and research support services providing scientists with access to specialized research equipment and expertise including imaging, genomics, and other core capabilities needed to advance translational neuroscience research.
• Pilot Grants Program Funding program providing seed grants to researchers to support preliminary studies and innovative research projects in neurodevelopmental disorders, accelerating early-stage translational work.
• Fellowships Training programs for researchers and clinicians to develop expertise in translational neuroscience and neurodevelopmental disorder research at the Translational Neuroscience Center.
• Psychology Practicum Clinical training opportunity for psychology students providing hands-on experience in pediatric neuropsychological assessment and research within the translational neuroscience framework.

Quantifiable outcome

• Developed disease concept model for Kleefstra syndrome identifying unique aspects that impact patient population and families
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

40 partnerships are on record, tiered core, flagship and minor.

• Boston Children's HospitalcoreStrategic or Co-development PartnerPrimary institutional affiliation providing hospital resources, clinical infrastructure, and administrative support for the Translational Neuroscience Center.
• Harvard Medical SchoolcoreStrategic or Co-development PartnerPrimary institutional affiliation providing academic resources, research faculty, and academic credibility for translational neuroscience research.
• Broad InstitutecoreStrategic or Co-development PartnerCollaborative research partner in base editing studies for trinucleotide repeat disorders including Huntington's disease and Friedreich's ataxia.
• IDefineflagshipStrategic or Co-development PartnerThe Kleefstra Syndrome Foundation partner collaborating on patient and caregiver-centered disease concept model research for Kleefstra syndrome.
• IFCR (International Foundation for CDKL5 Research)coreStrategic or Co-development PartnerPatient advocacy partner for CDKL5 Deficiency Disorder research and community engagement.
• Loulou FoundationcoreStrategic or Co-development PartnerPatient advocacy partner supporting research for neurodevelopmental disorders.
• NDSC (National Down Syndrome Congress)coreStrategic or Co-development PartnerAdvocacy partner representing Down syndrome community in translational research.
• NDSS (National Down Syndrome Society)coreStrategic or Co-development PartnerAdvocacy partner for Down syndrome research and community support.
• Dup15q AlliancecoreStrategic or Co-development PartnerAdvocacy partner for Dup15q syndrome research and family engagement.
• FRAXA Research FoundationcoreStrategic or Co-development PartnerAdvocacy partner supporting Fragile X syndrome research initiatives.
• FRAXAcoreStrategic or Co-development PartnerFragile X research foundation partner in advocacy and research.
• Cure AP4minorStrategic or Co-development PartnerAdvocacy partner for AP4-related disorders research.
• CRUE-SPG50minorStrategic or Co-development PartnerAdvocacy partner for Hereditary Spastic Paraplegia research.
• SFARI (Simons Foundation Autism Research Initiative)flagshipStrategic or Co-development PartnerMajor autism research foundation partner providing funding and research collaboration.
• SMA FoundationcoreStrategic or Co-development PartnerSpinal Muscular Atrophy advocacy and research partner.
• MDA (Muscular Dystrophy Association)coreStrategic or Co-development PartnerMuscular Dystrophy advocacy and research collaboration partner.
• PPMD (Parent Project Muscular Dystrophy)coreStrategic or Co-development PartnerDuchenne muscular dystrophy advocacy organization partner.
• PMSF (Phelan-McDermid Syndrome Foundation)coreStrategic or Co-development PartnerPhelan-McDermid Syndrome advocacy and research partner.
• CureSHANKcoreStrategic or Co-development PartnerSHANK gene-related disorders research advocacy partner.
• PTEN Hamartoma Tumor Syndrome FoundationcoreStrategic or Co-development PartnerPTEN-related disorders advocacy partner.
• RSRT (Rett Syndrome Research Trust)flagshipStrategic or Co-development PartnerMajor Rett syndrome research funding and advocacy organization.
• IRSF (International Rett Syndrome Foundation)coreStrategic or Co-development PartnerRett syndrome research and family support advocacy partner.
• RSA (Rett Syndrome Alliance)coreStrategic or Co-development PartnerRett syndrome alliance advocacy partner.
• MECP2 Duplication FoundationcoreStrategic or Co-development PartnerMECP2 Duplication Syndrome advocacy partner.
• Sturge-Weber FoundationcoreStrategic or Co-development PartnerSturge-Weber syndrome advocacy and research partner.
• SSADH Deficiency AssociationminorStrategic or Co-development PartnerSuccinic Semialdehyde Dehydrogenase Deficiency advocacy partner.
• SYNGAP1 FoundationcoreStrategic or Co-development PartnerSYNGAP1-Related Disorder advocacy and research partner.
• TSCA (Tuberous Sclerosis Alliance)coreStrategic or Co-development PartnerTuberous Sclerosis Complex advocacy partner.
• NORD (National Organization for Rare Disorders)flagshipStrategic or Co-development PartnerUmbrella rare disease organization providing advocacy network and resources.
• EveryLife FoundationcoreStrategic or Co-development PartnerRare disease advocacy foundation focused on policy and community support.
• NIH (National Institutes of Health)flagshipStrategic or Co-development PartnerFederal research funding agency and research collaboration partner.
• HHS (U.S. Department of Health and Human Services)flagshipStrategic or Co-development PartnerFederal health agency partner for research and policy.
• RDCRN (Rare Diseases Clinical Research Network)flagshipStrategic or Co-development PartnerNIH-funded network of rare disease research consortia.
• CAGS (CAG Sahel Alliance)minorStrategic or Co-development PartnerAdvocacy partner for CAG Sahel conditions.
• KDVSminorStrategic or Co-development PartnerAdvocacy partner for KDVS-related disorders.
• MED13 FoundationminorStrategic or Co-development PartnerMED13L Syndrome advocacy and research partner.
• ZTTKminorStrategic or Co-development PartnerZTTK syndrome advocacy partner.
• AGENDAminorStrategic or Co-development PartnerNeurodevelopmental disorder advocacy organization partner.
• ASF (Autism Science Foundation)coreStrategic or Co-development PartnerAutism research funding and advocacy foundation.
• RENminorStrategic or Co-development PartnerAdvocacy partner organization.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Stanley Center for Psychiatric Research at Broad Institute: Broad Institute-affiliated program working on psychiatric and neurodevelopmental disorders with emphasis on genetic approaches and rare disease cohorts. Direct collaboration partner of TNC and overlapping translational mission in CNS genetics.

Direct peers

• Marcus Autism Center: Pediatric autism and neurodevelopmental research center embedded within Children's Healthcare of Atlanta and affiliated with Emory. Directly comparable translational mission, pediatric patient population, and integration of clinical care with research.
• Cincinnati Children's Research Foundation: Top-tier pediatric research foundation with substantial translational neuroscience and rare disease programs housed within a leading children's hospital. Comparable patient population, grant funding model, and clinical research unit infrastructure.
• Kennedy Krieger Institute: Johns Hopkins-affiliated institute dedicated to pediatric neurodevelopmental disorders including autism, Rett, and Fragile X. Directly comparable translational research portfolio and patient advocacy engagement model for children with brain disorders.
• Children's Hospital of Philadelphia Research Institute: One of the largest pediatric research enterprises in the U.S., with overlapping neuroscience, gene therapy, and rare disease translational programs. Comparable in scale, institutional backing, and bench-to-bedside pipeline structure.
• UC Davis MIND Institute: Academic research institute specifically focused on neurodevelopmental disorders including autism, Fragile X, and Down syndrome. Directly comparable condition portfolio and translational research orientation.

Broad incumbents

• National Institute of Neurological Disorders and Stroke (NINDS): NIH institute funding and conducting neurological disease research including many of the conditions TNC targets. Comparable translational scope; functions as both research performer and major funder of TNC's external collaborators.
• McGovern Institute for Brain Research: MIT-based brain research institute with translational programs in neurodevelopmental and psychiatric disorders. Comparable academic affiliation model and gene therapy / circuit-level research, though broader portfolio.
• Allen Institute for Brain Science: Large, well-funded non-profit neuroscience research organization producing open brain science tools and atlases. Comparable non-profit academic research model and translational neuroscience scope, though broader and less pediatric-focused.

Others

• Simons Foundation Autism Research Initiative (SFARI): Major autism research funding foundation that is both a flagship partner of TNC and a parallel ecosystem builder. Comparable translational focus on neurodevelopmental disorders, but operates primarily as a funder rather than a clinical research center.

Market position

Strengths5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/rosamund-stone-zander-translational-neuroscience-center

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rosamund Stone Zander Translational Neuroscience Center